The 15th Annual Symposium on Neurovascular Disease

Saturday, January 27, 2024, 7:00 AM - 5:05 PM PST, Hotel Casa Del Mar, 1910 Ocean Way, Santa Monica, CA


The 15th Annual Symposium on Neurovascular Disease will provide attendees with updates on emerging technologies, including artificial intelligence in neurovascular and stroke imaging, new frontiers in stroke therapy, and updates on major neurovascular trials as a means of expediting the care of patients with stroke and other neurovascular diseases. A special session dedicated to cerebral aneurysms and AVMs will be offered, which will provide updates on AVM surgery after ARUBA, and radiosurgery for cerebral and spinal AVMs. The session with end with a discussion on different cerebral aneurysm cases. After lunch, a session on the management of stroke patients will cover anti-platelet therapy, genetic testing, AI imaging and stroke interventions. The final session will offer various other neurovascular topics including neuro-ophthalmologic diagnosis of vascular pathologies, mycotic aneurysms and dilemmas in stroke diagnosis and management An expert faculty has been assembled to discuss these important topics and the strategies to support healthcare professionals in delivering optimal care to their patients with neurovascular disease.

1. Discuss the rationale behind surgical decision making and the various treatment modalities for managing complex neurovascular symptoms
2. Discuss new techniques and treatment concepts for stroke and other complex neurovascular conditions
3. List some of the emerging technological treatments for complex neurovascular conditions
4. Examine unique case studies and the recommended strategies presented to address the clinical management of each

---

Physicians: $125
Nurse/Tech/Allied Health: $75

Refund Policy:
All cancellations must be submitted in writing and refunds will be subject to an administrative charge. To view the policy, click here. Please e-mail cancellation request to [email protected]. If you do not receive confirmation of your cancellation via e-mail, please call (310) 423-5548.

---

Disclaimer
All educational materials provided during and after the course are for your personal use only and should not be reproduced or distributed in any manner without the express permission of Cedars-Sinai.

Right to Cancel or Postpone
Cedars-Sinai reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event that Cedars-Sinai must cancel or postpone this course, the registration fee will be fully refunded. Cedars-Sinai is not responsible for any related costs, charges or expenses to participants, including fees assessed by airline, travel or lodging agencies.

Health and Safety Protocols
As you know, the health and safety of our community are always our top priorities at Cedars-Sinai. Participants in any event should be thoughtful about their individual risks and consider avoiding public gatherings if they are of higher risk.

Click here to review the current in-person Cedars-Sinai CME Event Protocols.

---

In support of improving patient care, Cedars-Sinai is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA Credit Designation Statement
Cedars-Sinai Medical Center designates this Live Activity for a maximum of 8.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Non-Physician AMA Attendance
Attendance credit will be provided to other healthcare professionals upon the fulfillment of attendance requirements. Participants should ensure in advance that their credentialing or licensing organization accepts AMA PRA Category 1 Credits™.  

 

ASRT Credit
Activity Approved by ASRT for CE credit(s) Category A

AMA PRA Category 1 Credit(s)™ (MD, DO) (7.50 hours), Non-Physician AMA Attendance (7.50 hours)

Mitigation of Relevant Financial Relationships

Cedars-Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Saturday, January 27, 2024

Neurovascular-Exhibitors by Cedars-Sinai CME